Combination therapy of HDACi together with PRC2 inhibitors like the EED inihibitor A-395, that interfere with chromatin binding of the PRC2/HDAC1/2 complex, significantly block tumor growth of EwS in a xenograft mouse model and could be an interesting new treatment option for this malignant disease. This evidence concerns the gene HDAC1 and neoplasm.